24,25-epoxycholesterol has been researched along with pregna-4,17-diene-3,16-dione in 1 studies
| Studies (24,25-epoxycholesterol) | Trials (24,25-epoxycholesterol) | Recent Studies (post-2010) (24,25-epoxycholesterol) | Studies (pregna-4,17-diene-3,16-dione) | Trials (pregna-4,17-diene-3,16-dione) | Recent Studies (post-2010) (pregna-4,17-diene-3,16-dione) |
|---|---|---|---|---|---|
| 65 | 0 | 18 | 175 | 2 | 105 |
| Protein | Taxonomy | 24,25-epoxycholesterol (IC50) | pregna-4,17-diene-3,16-dione (IC50) |
|---|---|---|---|
| Nuclear receptor subfamily 1 group I member 2 | Homo sapiens (human) | 0.0024 | |
| Glucocorticoid receptor | Homo sapiens (human) | 1.74 | |
| Progesterone receptor | Homo sapiens (human) | 1.2 | |
| Mineralocorticoid receptor | Homo sapiens (human) | 0.66 | |
| Androgen receptor | Homo sapiens (human) | 0.22 | |
| Vitamin D3 receptor | Homo sapiens (human) | 2 | |
| Bile acid receptor | Homo sapiens (human) | 6.075 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Castell, JV; Gómez-Lechón, MJ; Jover, R; Moya, M | 1 |
1 other study(ies) available for 24,25-epoxycholesterol and pregna-4,17-diene-3,16-dione
| Article | Year |
|---|---|
Enhanced steatosis by nuclear receptor ligands: a study in cultured human hepatocytes and hepatoma cells with a characterized nuclear receptor expression profile.
Topics: Androstenols; Bridged Bicyclo Compounds; Calcifediol; Cells, Cultured; Cholesterol; Farnesol; Fatty Liver; Hep G2 Cells; Hepatocytes; Humans; Indoles; Ligands; Phloroglucinol; PPAR gamma; Pregnenediones; Receptors, Cytoplasmic and Nuclear; Selective Estrogen Receptor Modulators; Tamoxifen; Terpenes; Vitamin A | 2010 |